In accordance with Regulations 30 read with Schedule III of the SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015, Sai Life Sciences has informed that meeting with Analyst / Investor is scheduled as on March 11, 2025.
The above information is a part of company’s filings submitted to BSE.